- Home
- GROY vs HRTX Comparison
GROY vs HRTX Comparison
Compare GROY & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- HRTX
- Stock Information
- Founded
- GROY 2020
- HRTX 1983
- Country
- GROY Canada
- HRTX United States
- Employees
- GROY N/A
- HRTX N/A
- Industry
- GROY
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- GROY
- HRTX Health Care
- Exchange
- GROY Nasdaq
- HRTX Nasdaq
- Market Cap
- GROY 231.6M
- HRTX 263.9M
- IPO Year
- GROY 2021
- HRTX 1987
- Fundamental
- Price
- GROY $1.42
- HRTX $1.75
- Analyst Decision
- GROY Strong Buy
- HRTX Strong Buy
- Analyst Count
- GROY 3
- HRTX 3
- Target Price
- GROY $3.58
- HRTX $6.00
- AVG Volume (30 Days)
- GROY 853.2K
- HRTX 1.3M
- Earning Date
- GROY 11-04-2024
- HRTX 11-12-2024
- Dividend Yield
- GROY N/A
- HRTX N/A
- EPS Growth
- GROY N/A
- HRTX N/A
- EPS
- GROY N/A
- HRTX N/A
- Revenue
- GROY $7,764,000.00
- HRTX $136,361,000.00
- Revenue This Year
- GROY $329.59
- HRTX $18.46
- Revenue Next Year
- GROY $77.98
- HRTX $21.59
- P/E Ratio
- GROY N/A
- HRTX N/A
- Revenue Growth
- GROY 197.02
- HRTX 15.60
- 52 Week Low
- GROY $1.17
- HRTX $0.53
- 52 Week High
- GROY $2.21
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- GROY 48.70
- HRTX 42.72
- Support Level
- GROY $1.32
- HRTX $1.70
- Resistance Level
- GROY $1.55
- HRTX $1.85
- Average True Range (ATR)
- GROY 0.06
- HRTX 0.10
- MACD
- GROY -0.01
- HRTX 0.00
- Stochastic Oscillator
- GROY 39.58
- HRTX 16.67
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and streaming company. It offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.